Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
The Molecular Diagnostics - Infectious Disease sector offers growth opportunities with biotech advancements, particularly in genomics. Key trends include nucleic acid testing and immunoassay ...
Attendees interested in learning more about CoSara products, including the TB and HPV tests on the Company's upcoming Co-Dx PCR platform, are encouraged to stop by at VIROCON 2025. CoSara will be ...
The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...
Analysts launch bullish coverage on BillionToOne as its IPO surge, prenatal growth, and molecular diagnostics platform drive ...
Biotechnology has spurred countless innovations in medicine, ultimately improving patient outcomes through enhanced understanding of pathogenic mechanisms, better diagnostic assays, and more effective ...
Groundbreaking research in The Journal of Molecular Diagnostics shows that analysis of specific patterns of cell-free DNA ...
Lung Cancer Diagnostics Market OverviewThe global lung cancer diagnostics market is undergoing significant expansion as healthcare systems, technology developers, and research institutions intensify ...
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has added Jack J. Phillips to serve on its ...
When studying human diseases, the first step is to identify the root cause. But how do scientists find out if the culprit is a genetic mutation, a virus, or something else entirely? Using molecular ...
Gastric Cancer Diagnostics Market size was valued at US$ 3.5 Bn in 2024 and is projected to reach US$ 6.9 Bn by 2035, growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback